Association Between Cost-Sharing and Buprenorphine Prescription Abandonment-Reference-Cited by-同舟云学术

Association Between Cost-Sharing and Buprenorphine Prescription Abandonment

Published:2024-06-18 Issue:12 Volume:39 Page:2160-2168
ISSN:0884-8734
Container-title:Journal of General Internal Medicine
language:en
Short-container-title:J GEN INTERN MED

Author:

Chua Kao-Ping^ORCID,Conti Rena M.,Lagisetty Pooja,Bohnert Amy S. B.,Nuliyalu Usha,Nguyen Thuy D.

Funder

National Institute on Drug Abuse

Gorman Scholar Award, University of Michigan

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11606-024-08819-2.pdf

Reference26 articles.

1. National Academies of Sciences, Engineering, and Medicine. 2019. Medications for Opioid Use Disorder Save Lives. Washington, DC: The National Academies Press. https://doi.org/10.17226/25310.

2. Larochelle MR, Bernson D, Land T, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med. 2018;169(3):137-145. https://doi.org/10.7326/M17-3107.

3. Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550. https://doi.org/10.1136/bmj.j1550.

4. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2022 National Survey on Drug Use and Health. 2023. https://www.samhsa.gov/data/sites/default/files/reports/rpt42731/2022-nsduh-nnr.pdf. Accessed 15 May 2024.

5. Chua KP, Nguyen TD, Zhang J, Conti RM, Lagisetty P, Bohnert AS. Trends in buprenorphine initiation and retention in the United States, 2016-2022. JAMA. 2023;329(16):1402-1404. https://doi.org/10.1001/jama.2023.1207.